11 - 12 November 2025 | London, UK
Connecting Leaders From Every Stage of the Value Chain to Drive Advanced Therapy Development & Novel Biologics Processing
Welcome to Cell 2025, Oxford Global’s flagship event bringing together leaders from pharma, biotech, academia, and regulatory institutions across the entire cell culture and cell & gene therapy value chain.
From discovery and development to manufacturing, supply chain, logistics, and commercialisation, our agenda covers every critical stage. Featuring the Cell Culture & Bioprocessing, Advanced Therapy Development, and Cell & Gene Therapy Manufacturing programmes, this event is jam-packed with cutting-edge presentations, C-level discussions, technology & investor showcases, and unparalleled networking opportunities. Dive into pioneering strategies and innovative technologies driving the future of advanced therapies. Don’t miss out on staying ahead of breakthrough advancements set to shape the cell culture and cell & gene therapy markets.
Cell & Gene Therapy Manufacturing
- Hear from and meet with the key innovators in cell & gene therapy manufacturing. 2024 attendees included: Director Product Supply Cell & Gene, BioNTech SE; Vice President, Clinical Strategy and Development, Medigene; Chief Scientific Officer, CellProthera
- Take a deep dive into strategies for gene therapy manufacturing. Key opinion leaders will cover the challenges associated with scale-up, utilising single-use technologies and sustainable manufacturing practices
- Benefit from the latest development in supply chain & logistics. Presentations will address regulatory compliance in transportation, shipping & tracking of new modalities in the clinic & collaborations across the supply chain
- Explore strategies for cell therapy manufacturing with topic areas such as autologous vs allogenic products, automation & digitalisation, transitioning from R&D to clinical manufacturing & the path towards commercialisation
- Take advantage of a wide range of interactive sessions onsite. 2024 panel discussions included: ‘Strategies For Navigating Evolving Regulatory Landscapes’; ‘CGT IP Challenges & Strategies’; ‘How To Troubleshoot Cell Line Engineering & Development Bottlenecks’ and many more
Agenda at a Glance
Day One
Track 1: Strategies for Gene Therapy Manufacturing
Track 2: Supply Chain & Logistics
Day Two
Track 1: Strategies for Cell Therapy Manufacturing
Advanced Therapy Development
- New to 2025! Take a deep dive into regulatory considerations for cell & gene therapies. Key opinion leaders will be covering the regulations surrounding the development of platforms for genetically modified B cells and using accelerated regulatory pathways
- New to 2025! Gain invaluable insights into tissue engineering development, with presentations addressing stem cells for cartilage, biomaterials for tissue engineering and tissue engineering with different cell types
Agenda at a Glance
Day One
Track 1: Novel Strategies for Gene Therapy Discovery & Development
Track 2: Cell & Gene Therapy Analytics & Quality Control
Track 4: Tissue Engineering Development
Day Two
Track 1: CGT Clinical Development & Clinical Trials
Track 2: Cell Therapy Development
Track 3: iPSCs and Stem Cell Therapy Development
Track 4: Regulatory Considerations & Commercialisation for Cell & Gene Therapies
Cell Culture & Bioprocessing
- Hear from and meet with the key innovators in cell culture & bioprocessing. 2024 attendees included: Chief Scientific Officer, Medigene AG; Senior Vice President, Global Regulatory Affairs, BioNTech SE
- New to 2025! Gain invaluable insights into innovations in pre-clinical assay development & 3D cell cultures. Key opinion leaders will be addressing the integration of iPSC models for pre-clinical studies, 2D versus 3D cultures and case studies highlighting pre-clinical successes and failures
- New to 2025! Take a deep dive into the latest strategies for enabling successful cell line engineering – improving efficiency and removing bottlenecks in cell line development, screening clones for productivity and titer & predicting and characterising clones
- Devised with the help of our esteemed advisory board. Key presentations will cover gene delivery in drug discovery, automation & digitalisation in bioprocessing and techniques for enhancing cell culture productivity
- New to 2025! Join thought-leader panel discussions, investor-focused sessions and roundtables pertaining to the latest in cell culture & bioprocessing
Agenda at a Glance
Day One
Track 1: Cell Line Engineering Ensuring Stability, Quality & Clonality
Track 2: Upstream & Downstream Bioprocessing: Novel Technologies & Continuous Processing
Day Two
Track 1: Gene Delivery & Gene Editing for Cell Line Development
Track 2: Innovations in Pre-Clinical Assay Development, Cell Culture Media Optimization & 3D Cultures: From In Vitro Models to Translational Success
Explore the Cell 2025 Programme
Networking & knowledge-sharing is at the heart of what we do, with 230 hours of pre-arranged 1-2-1 meetings and over 12 hours of networking, don't miss the opportunity to connect with 1,000 leaders from across pharma, biotech, regulatory and academia.
Engaging Thought Leadership
Experience over 30 hours of interactive discussions, thought leadership debates, and collaborative roundtables, with insights from industry leaders to benchmark your research & development pipeline.
Global Technology Showcase
An international exhibition showcasing cutting-edge technologies and services from premier providers in the scientific field.
Networking Emphasis
Unparalleled networking opportunities, including personalised 1-2-1 meetings, a start-up zone, vibrant drinks reception, and informal gatherings to foster meaningful connections.
Start-up Zones & Awards Ceremony
Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and start-up companies.
leading pharma, biotech, regulatory & academic delegates
Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration, including:
Panel Discussion: What Is The Next Game Changer In Antibody Engineering?
Moderator: Karen Silence, Head Preclinical Product Development, ArgenX
Panellists include Berit Olsen Krogh, Senior Research Fellow; and Lundbeck Andrew Buchanan, Principal Scientist, AstraZeneca
Roundtable: Regulatory Insights On Bringing A Peptide To Human Trials
Moderator: Paul Reid, Co-Founder & Chief Scientific Officer, Celtic Bio
Workshop: Development Of Targeted Delivery Systems
Two Presentations, followed by a Panel Discussion on 'The Next Chapter Of Oligonucleotide Delivery'
Moderator: Steve Hood, Senior Director, Oligonucleotide ADME Strategy, GSK
Panel Discussion: Navigating The Paradigm Shift Towards Greener Approaches
Moderator: Walter Cabri, Full Professor of Organic Chemistry, University of Bologna
Panellists include Daniel Sejer Pedersen, Chemical Development Specialist CMC API Development, Novo Nordisk;
Anna Maria Papini, Full Professor & Group Leader, University of Florence;
Louis Diorazio, Senior Principal Scientist, New Modalities, AstraZeneca;
Alessandra Tolomelli, Associate Professor, University of Bologna
Presentation: How The RNA Technologies Could Help To Prevent Infectious Diseases And Could Be Applied To Various Chronic Disease Immunotherapies?
Presented by: Daniel Larocque, Innovation Lead, Innovation and Emerging Science, Sanofi
Who is Speaking at NextGen Biomed 2025?
Speakers of Cell 2024 Included:
Interested in Sponsoring Cell 2025?
Become a driving force in connecting leaders from every stage of the value chain to drive advanced therapy development & novel biologics processing. Cell 2025 offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
Interested in Sponsoring NextGen Biomed?
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
Sponsors of Cell 2024 Included
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Network & Programme Sponsors
Start-Ups
The 1-2-1s are the best thing about Oxford Global events, well organised and good number of relevant contacts. Good high level contacts from big companies.
Advanced Therapies Specialist Team Leader,
Genscript
Biologics 2024 has been one of the best events I have attended so far in my career.
Territorial Sales Manager UK,
ACROBiosystems Co., Ltd.
Impressed by the effort to bring people together.
Business Development Director,
Bioassay
Nice set-up, with good support for exhibitors
Director of Client Relations,
ImmunoPrecise
The start-up zone provides a unique opportunity to for you to exhibit, network, and pitch to our global audience of pharma, biotech, and investment professionals.
It's designed for start-ups from across the biologics space, working on cutting-edge therapies, innovative platform technologies, products, and solutions and is an ideal platform to share your business plans.
There are two options, based on the size of your organisation with prices starting from £1,500 (+VAT).
For further information and to get started submit the application form below.
Criteria:
To qualify your company must be:
- Therapeutic Start-Up, Emerging Technology OR Service Start-Up
- Operating No More Than 5 Years
- 0 – 30 employees
- Pre-Series A Funding
Successful applications receive:
- 1 Full Conference Pass
- 10-Minute Presentation Opportunity
- 1x1m Space in Start-Up Zone
- Logo Featured on Event Website & App as a Participating Start-Up
- Ability to Arrange Peer to Peer Meetings via the Congress App
The NextGen Biomed Best Poster Presentation Competition & Award includes the best poster presentation award and is intended to honour an outstanding individual performance for a scientific work by either an early career or established scientist, including PhD student and PostDocs.
Please submit your poster presentation by no later than 13th January 2025 in the below category:
- Protein/Antibody Engineering
- Bioanalysis & Characterisation
- Next Generation Biotherapeutics
- Peptides Chemistry & Therapeutics
- Oligonucleotides Chemistry & Therapeutics
- Sustainable Chemistry & Manufacturing
-
- Open to all scientists, including students (PhD), PostDocs, and established researchers representing pharma & biotech companies and/or academic institutions
- Applicants must be the first AND presenting author of the submitted paper and register for the meeting by 13th January 2025
- ONLY ONE submission per person will be accepted. If authors submit multiple abstracts for consideration for the competition, only one abstract will be taken into consideration
Applicants must follow the procedure as follows:
- Register and submit an abstract by 13th January 2025 using the registration link to the right on this page. Please ensure you add the poster display option on the registration page to secure your admission into the Best Poster Competition & Award
- Once registered you will be provided with the online abstract submission form
- Prepare the poster or platform and present it (The poster presenter should be at the poster during all breaks.)
- The winner with the highest scores will be announced at the Morning Networking Break on Day 3 of the event
The poster presentations will be evaluated by everyone attending the event on the basis of originality of the approach and quality of the work (e.g. appropriate methodology, interpretation of results, conclusiveness). Attendees will be allowed to cast one vote by selecting their favourite work in the poster area. All votes will be counted at the end of Day 2 at 5pm and results will be announced during the morning networking break on Day 3. .
The winners receiving the highest scores will be announced at the Morning Networking Break on Day 3 and will be given a trophy as well as £600 contribution towards travel & accommodation costs to attend the 2026 NextGen Biomed event. Oxford Global will also provide winners with PLUS Pass – 12 months access to our digital content platform providing access to on-demand presentations, exclusive reports and highlights.